Yield pearls for your depot come from this Swiss laboratory – and other stock market tips of the week
In “Switzerland at the weekend”, our money columnist François Bloch writes why Tecan is so brilliant on the stock exchange, why Novo Nordisk is a safe bet and why he never backed CS.
On March 28th you will receive the annual dividend due to the stock holdings Novo Nordisk (NOVO B DC) transferred, but otherwise you will get a maximum of 311 billion Swiss francs from the diabetes specialist. With an investment return of +283.4% in local currency over the last five years, there is no reason to sell the paper prematurely. The return on equity employed should reach a new record of 79.2% this year. (reload)
